Co-silencing of Birc5 (survivin) and Hspa5 (Grp78) induces apoptosis in hepatoma cells more efficiently than single gene interference

International Journal of Oncology
Qiang WangPing Lei

Abstract

Birc5 (previously known as survivin) is a cancer-specific protein. Due to the upregulation of its expression in various human malignancies and its key role in apoptosis, proliferation and angiogenesis, Birc5 has attracted attention as a target for anticancer therapies. In this study, when Birc5 was silenced in HepG2 cells, 29.7±3.3% cells underwent apoptosis as expected. It was found that the expression levels of glucose-regulated protein 78 (Hspa5, previously known as Grp78) was increased by almost 3-fold in Birc5-silenced HepG2 cells. Hspa5, a master regulator of the anti-apoptotic unfolded protein response signalling network, can also promote tumor proliferation, survival and metastasis. Hence, we hypothesized that the co-silencing of Birc5 and Hspa5 may exert a stronger apoptosis-inducing effect than single gene interference. To verify this, the expression levels of Birc5 and Hspa5 in human hepatocellular carcinoma tissues were determined. Immunohistochemical staining showed that the expression of Birc5 and Hspa5 was elevated in 28 out of 31 samples. Additionally, plasmid-based siRNA against Birc5 and/or Hspa5 were constructed and transfected into the human hepatocellular liver carcinoma cell line, HepG2. Compared with the ...Continue Reading

References

Jan 2, 2003·Nature Reviews. Cancer·Dario C Altieri
Nov 14, 2003·Proceedings of the National Academy of Sciences of the United States of America·Paola FortugnoDario C Altieri
Dec 4, 2004·International Journal of Cancer. Journal International Du Cancer·Fengzhi LiDongfeng Tan
Feb 14, 2006·Current Molecular Medicine·Jianze Li, Amy S Lee
Aug 3, 2006·Journal of the National Cancer Institute·Boglarka GyurkoczaDario C Altieri
Mar 8, 2007·Carcinogenesis·Marzia PennatiNadia Zaffaroni
Oct 11, 2008·International Journal of Cancer. Journal International Du Cancer·Wen-Jie HuangUNKNOWN De-AnTian
May 28, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Julian A SchardtThomas Pabst
Dec 18, 2009·Proteomics·Serge ArnaudeauMarie Cohen
Mar 10, 2010·Current Drug Targets·Eishi AshiharaTaira Maekawa
Jan 11, 2011·Molecular Cancer Therapeutics·Rosa A CarrascoBharvin K R Patel
Feb 19, 2011·Methods in Enzymology·Sakae Saito, Akihiro Tomida

❮ Previous
Next ❯

Citations

Sep 6, 2014·International Journal of Molecular Sciences·Angelica Judith Granados López, Jesús Adrián López
May 3, 2021·European Journal of Medicinal Chemistry·Meizhu WangWen Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.